Showing results (31-40 of 329) with videos related to

Sort By:
Pageof 33
Journal of Clinical Lipidology|September 27, 2012
Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoproteinAllan D Sniderman, Andre Tremblay, Jacqueline De Graaf, et al.
Journal of Clinical Lipidology|December 3, 2010
When is equal not equal?Allan D Sniderman, Ken Williams, Matthew J McQueen, et al.
Journal of Clinical Lipidology|September 29, 2016
An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoBAllan D Sniderman, Peter P Toth, George Thanassoulis, et al.
Atherosclerosis|April 22, 2014
Calculation of LDL apoBAllan D Sniderman, André J Tremblay, Jacqueline De Graaf, et al.
Journal of the American Heart Association|July 25, 2023
Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-CholesterolJohn H Contois, Michel R Langlois, Christa Cobbaert, et al.
Diabetes Care|March 5, 2002
Hypertriglyceridemic hyperapoB in type 2 diabetesAllan D Sniderman, Benoit Lamarche, Jessica Tilley, et al.
Current Opinion in Lipidology|October 12, 2011
Should preclinical vascular abnormalities be measured in asymptomatic adults to improve cardiovascular risk stratification?Jacqueline de Graaf, Suzanne Holewijn, Anton F Stalenhoef, et al.
Current Opinion in Lipidology|October 24, 2014
Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoBAllan D Sniderman, Benoit Lamarche, John H Contois, et al.
International Journal of Epidemiology|May 19, 2007
Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesisAllan D Sniderman, Raj Bhopal, Dorairaj Prabhakaran, et al.
Nephrology (Carlton, Vic.)|October 9, 2016
Serial versus single troponin measurements for the prediction of cardiovascular events and mortality in stable chronic haemodialysis patientsThomas A Mavrakanas, Allan D Sniderman, Paul E Barré, et al.
Pageof 33